Pharmacokinetics of Apixaban in Nephrotic Syndrome

Completed · Phase 1

Conditions studied: Nephrotic Syndrome, Proteinuria

In brief

This study is to investigate the pharmacokinetics and pharmacodynamics of apixaban in nephrotic syndrome.

Key facts

Study ID

NCT02599532

Run by

University of North Carolina, Chapel Hill

People needed

21

Starts

2017-04-30

Expected to finish

2019-06-28

Last updated by the study team

2019-07-24

Who can join

Age: 18 and older, up to 79. Sex: any. Healthy volunteers: accepted.

Where it is running

• University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.